Abstract
For several years, the primary function of CD40 ligand (CD40L) has been believed to be in regulation of contact-dependent, CD40-CD40L-mediated signals between B-and T-cells, which are essential for the regulation of thymus-dependent (TD) humoral immune responses. Recently, a flurry of reports indicate that CD40 is expressed by variety of cell types other than B-cells that include dendritic cells, follicular dendritic cells, monocytes, macrophages, fibroblasts, and endothelial cells. These studies show that CD40-CD40L interactions are important in inflammatory process. For the past few years, through the availability of CD40L-knockout mice, new data have emerged to support the belief that CD40L has many more functions than its role in TD humoral immunity. CD40L-deficient mice have provided significant information towards our understanding of the in vivo role of CD40L. The current picture that emerges indicates that CD40-CD40L interactions mediate many cell-mediated immune responses and T-cell-mediated effector functions that are required for proper functioning of the host defense system. This article focuses on the in vivo role of the CD40L in regulation of cell-mediated effector functions.
Similar content being viewed by others
References
Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, vanKooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Ann Rev Immunol 1994; 12: 881–922.
Armitage RJ, Fanslow WC, Strock-bine L, Sato TA, Clifford KN, Macduff BM, et al.: Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80–82.
Cocks BG, de Waal MalefytR, Galizzi JP, de VriesJE, Aversa G: IL-13 induces proliferation and differentiation of human B-cells activated by the CD40 ligand. Intl Immunol 1993;5:657–663.
Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy JY: Induction of human IgE synthesis in B-cells by mast cells and basophils. Nature 1993;365:340–343.
Lederman S, Yellin MJ, Krichevsky A, Belko J, Lee JJ, Chess L: Identification of a novel surface protein on activated CD4+ T cells that induces contactdependent B cell differentiation (help). J Exp Med 1992;175:1091–1101.
Noelle RJ, Ledbetter JA, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymusdependent B-cell activation. Immunol Today 1992;13:431–433.
Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B-cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543–1550.
Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T-cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B-cell co-stimulatory activity. EMBO J 1992;11: 4313–4321.
Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T-cells. Eur J Immunol 1992;22:3191–3194.
Grewal IS, Flavell RA: CD40-CD40L interactions in T-cell activation. Immunol Rev 1996;153: in press.
Callard RE, Armitage RJ, Fanslow WC, Spriggs MK: CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14:559–564.
Foy TM, Aruffo A, Ledbetter JA, Noelle RJ: In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J Exp Med 1993;178:1567–1575.
Ramesh N, Fuleihan R, Geha, R: Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Immunol Rev 1994;138:87–104.
Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1994;1:423–431.
Renshaw BR, Fanslow WC, Armitage RJ, Cambell KA, Liggit D, Wright B, et al.: Humoral immune responses in CD40 liganddeficient mice. J Exp Med 1994;180: 1889–1900.
Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994 ;1:167–178.
Grewal IS, Xu J, Flavell RA: Impairment of antigenspecific T-cell priming in mice lacking CD40 ligand. Nature 1995;378: 617–620.
Grewal IS, Flavell RA A central role of CD40 ligand in the regulation of CD4 T-cell responses. ImmunolToday 1996;17:410–414.
Grewal IS, Flavell RA: Role of CD40 ligand in immunity and autoimmunity; in Plotkin S, Fantini B (eds.)Immune Tolerance. Elsevier, Paris: 1996, in press.
Noelle RJ: CD40 and its ligand in host defense. Immunity 1996;4: 415–419.
Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T-cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995 ; 182:1857–1864.
Eynon EE, Parker DC: Small B cells as antigenpresenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992;175:131–138.
Fuchs EJ, Matzinger P:B cells turn off virgin but not memory T cells. Science 1992;258:1156–1159
Linsley PS, Ledbetter JA.: The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 1993; 11:191–212
Janeway CA Jr, Bottomly K: Signals and signs for lymphocyte responses. Cell 1994;76:275–285
Jenkins MK: The ups and downs of T cell costimulation. Immunity 1994;1:443–446
Ranhei, EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993;177:925–935.
Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R: Studies on the interdependence of gp39 and B7 expression and function during antigenspecific immune responses. Eur J Immunol 1995; 25:596–603.
Kearne, RR, Pape KA, Loh DY, Jenkins MK: Visualization of peptidespecific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;94:327–339.
Wu Y, Xu J, Shinde S, Grewal, IS, Henderson T, Flavell RA, Liu Y: Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol 1995;5:1303–1311.
Buhlmann JE, Foy TM, Aruffo A, Crassi KM, Ledbetter JA., Green, WR, Xu J, Shultz LD, Roopesian D, Flavell RA, Loran F, Noelle RJ, Durie FH: In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995;2:645–653.
Lin H, Boiling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA: Longterm acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donorspecific transfusion. J Exp Med 1993;178:1801–1808.
Boiling SF, Lin H, Wei RQ, Linsley P, Turka LA: The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J Surg Res 1994;57:60–64.
Caux C, Massacrier C, Vanbervliet B, Dubois B, VanKootenC, Durand I, Banchereau J: Activation of human dendritic cells through CD40 crosslinking. J Exp Med 1994;180:1263–1272.
Peguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, VanKooten C, Banchereau J, Schmitt D: Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 1995;155:4241–4247.
Cella M, Scheidegger D, Palmer-Lehman K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184;747–752.
Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G: High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-10. J Exp Med 1996;184:741–746.
Aversa G, Punnonen J, deVries JE: The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med 1993;177:1575–1585.
Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S: Membrane tumour necrosis factoralpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 1993;63:464–466.
Rodriguez C, Roldan E, Navas G, Brieva JA: Essential role of tumor necrosis factoralpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and highrate immunoglobulin secretion. Eur J Immunol 1993;23:1160–1164.
Larrick JW, Wright SC:Cytotoxic mechanism of tumor necrosis factoralpha. FASEB J 1990;4: 3215–3223.
Hernandez-Caselles T, Stutman O: Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol 1993; 151:3999–4012.
Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992;3:101–122.
Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ: Prevention of collageninduced arthritis with an antibody to gp39, the ligand for CD40. Science 1993; 261:1328–1330.
Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995;154:1470–1480.
Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Ciaassen E: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996;93:2499–2504.
Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KS: The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 1996;183:801–810.
Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995;92:4342–4346.
Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155–157.
McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD: Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182: 75–85.
Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA Jr, Flavell RA: Requirement for CD40 ligand in costimulation induction, T cell activation and experimental allergic encephalomyelitis. Science 1996;273:1864–1867.
Stout R, Suttles J: The many roles of CD40: CD40L interactions in cell-mediated inflammatory responses. Immunol Today 1996; 17:487–492.
Stout R, Suttles J, Xu J, Grewal I, Flavell R: Impaired T cell-mediated macrophage activation in CD40 liganddeficient mice. J Immunol 1996;156:8–11.
Wagner DH Jr, Stout RD, Suttles J: Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 1994;24:3148–3154.
Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917–4925.
Tao X, Stout RD: T-cell-mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells. Eur J Immunol 1993;23:2916–2921.
Tian L, Noelle RJ, Lawrence DA: Activated T-cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995;25: 306–309.
Stout RD: Macrophage activation by T cells: cognate and noncognate signals. Curr Opinion Immunol 1993;5:398–403.
Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delespesse G: Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125–1128.
Afonso LC, Scott P: Immune responses associated with susceptibility of C57BL/10 mice toLeishmania amazonensis. Infect Immun 1993;61:2952–2959.
Reiner SL, Locksley RM: The regulation of immunity toLeishmania major. Ann Rev Immunol 1995;13:151–177.
Soong L, Xu J, Grewal IS, Kima P, Sun J, Longley JrBJ, Ruddle NH, McMohan-Pratt D, Flavell RA: Disruption of CD40-CD40 ligand interactions results is an enhanced susceptibility toLeishmania amazonensis infection. Immunity 1996; 4:263–273.
Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed, SG, Maliszewski, CR: CD40 Ligand is required for protective cell-mediated immunity toLeishmania major. Immunity 1996;4:283–289.
Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H: Protective role of CD40 inLeishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275–281.
Borrow P, Tishon A, Lee S, Xu J, Grewal IS, Oldstone MB, Flavell RA: CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 1996; 183:2129–2142.
Whitemire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R: CD40 liganddeficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J Virol 1996;70:8375–8381.
Kasaian MT, Leite-Morris KA, Biron CA: The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J Immunol 1991;146:1955–1963.
Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM: Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol 1994;68:4700–4704.
vonHerrath MG, Yokoyama M, Dockter J, Oldstone MB, Whitton JL: CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996;70: 1072–1079.
Ding L, Green JM, Thompson CB, Shevach EM: B7/CD28-dependent and independent induction of CD40 lig and expression. J Immunol 1995;155:5124–5132.
Jaiswal AI, Dubey C, Swain SL, Croft M, Regulation of CD401 igand expression on naive CD T cells: a role for TCR but not co-stimulatory signals. Intl. Immunol 1996; 8:275–285.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grewal, I.S., Flavell, R.A. The Cd40 ligand. Immunol Res 16, 59–70 (1997). https://doi.org/10.1007/BF02786323
Issue Date:
DOI: https://doi.org/10.1007/BF02786323